Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 10-2001 | 09-2001 | 06-2001 | 04-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,030 | -1,030 | -1,030 | -1,670 | -1,670 |
| Depreciation Amortization | 50 | 50 | 50 | 70 | 70 |
| Other Working Capital | 80 | 80 | 80 | -140 | -140 |
| Other Operating Activity | 10 | 10 | 10 | 210 | 210 |
| Operating Cash Flow | $-890 | $-890 | $-890 | $-1,530 | $-1,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -190 | -190 | -190 | -240 | -240 |
| Other Investing Activity | -20 | -20 | -20 | -70 | -70 |
| Investing Cash Flow | $-210 | $-210 | $-210 | $-310 | $-310 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 350 | 350 | 350 | 640 | 640 |
| Financing Cash Flow | $350 | $350 | $350 | $640 | $640 |
| Beginning Cash Position | 4,250 | 4,250 | 4,250 | 5,460 | 5,460 |
| End Cash Position | 3,490 | 3,490 | 3,490 | 4,250 | 4,250 |
| Net Cash Flow | $-750 | $-750 | $-750 | $-1,210 | $-1,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -890 | -890 | -890 | -1,530 | -1,530 |
| Free Cash Flow | -890 | -890 | -890 | -1,530 | -1,530 |